• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜静脉阻塞的黄斑动力学和视力预后——连接的途径。

Macular dynamics and visual acuity prognosis in retinal vein occlusions - ways to connect.

机构信息

Department of Ophthalmology, "Victor Babeş" University of Medicine and Pharmacy, Timişoara, Romania.

Oculens Clinic, Cluj Napoca, Romania.

出版信息

Rom J Ophthalmol. 2023 Jul-Sep;67(3):312-324. doi: 10.22336/rjo.2023.51.

DOI:10.22336/rjo.2023.51
PMID:37876516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10591427/
Abstract

This study aimed to establish possible connections between macular dynamics, various macular features, and visual acuity prognosis among patients with retinal vein occlusions. This study included 85 patients with central retinal vein occlusions (CRVO) and 26 with branch retinal vein occlusions (BRVO). We assessed macular features such as central macular thickness (CMT), foveal intraretinal hemorrhage (IRH), the presence and distribution of hyperreflective foci (HF), ellipsoid zone (EZ) disruption, inner retinal layer disorganization (DRIL), and posterior vitreous detachment (PVD), as well as their dynamics over one year of observation and their impact on final visual acuity prognosis, depending on the type of occlusion. Best corrected visual acuity (BCVA) evolution is statistically significant regarding groups of age and type of occlusion and insignificant regarding gender. The best response to intravitreal treatment, quantified as a decrease in CMT, was registered after the first intravitreal injection. Connecting a decrease in CMT with BCVA improvement, we did not register a statistically significant correlation in the CRVO group, only in BRVO cases. The study results showed that complete PVD plays a significant positive role in decreasing CMT and BCVA improvement in cases of CRVO. Our study revealed that no matter the type of occlusion, the presence of foveal IRH will have a negative impact on the BCVA outcome. Statistically significant differences have been noted only for the evolution of visual acuity in non-ischemic CRVO cases, in correlation with the presence of EZ disruption. Outer retinal layer HF has proved to be a predictive factor for poor visual acuity outcomes. The most important non-imaging predicting factors regarding BCVA after retinal vein occlusions are age and baseline BCVA. CMT's dynamics still establish a weak connection with visual acuity fluctuations. The presence of foveal IRH, outer retinal layer HF, and foveal EZ disruption has a negative impact on visual acuity outcomes. CRVO = central retinal vein occlusions, BRVO = branch retinal vein occlusions, CMT = central macular thickness, IRH = foveal intraretinal hemorrhage, HF = hyperreflective foci, EZ = ellipsoid zone disruption, DRIL = inner retinal layer disorganization, PVD = posterior vitreous detachment, BCVA = best corrected visual acuity, OCT = optical coherence tomography, BCVA Ti = best corrected visual acuity at first, BCVA Tf = best corrected visual acuity after one year, NR of IVI = number of intravitreal injections, SD = standard deviation, M = male, F = female, CMT Ti = central macular thickness at first, CMT T1 = central macular thickness after first injection, CMT T3 = central macular thickness after 3 injections, CMT Tf = central macular thickness after one year.

摘要

本研究旨在确定视网膜静脉阻塞患者的黄斑动力学、各种黄斑特征与视力预后之间的可能联系。该研究纳入了 85 例中心性视网膜静脉阻塞(CRVO)患者和 26 例分支性视网膜静脉阻塞(BRVO)患者。我们评估了黄斑特征,如中央视网膜厚度(CMT)、黄斑区视网膜内出血(IRH)、高反射焦点(HF)的存在和分布、椭圆体带(EZ)中断、内视网膜层组织紊乱(DRIL)和玻璃体后脱离(PVD),以及它们在一年观察期内的动态变化及其对最终视力预后的影响,这取决于阻塞的类型。最佳矫正视力(BCVA)的演变在年龄和阻塞类型的分组上具有统计学意义,而在性别上无统计学意义。在第一次玻璃体腔内注射后,CMT 的下降与玻璃体腔内治疗的最佳反应相关,且具有统计学意义。我们没有在 CRVO 组中观察到 CMT 下降与 BCVA 改善之间的统计学显著相关性,而仅在 BRVO 病例中观察到。研究结果表明,完全性 PVD 在 CRVO 病例中对 CMT 降低和 BCVA 改善具有显著的积极作用。我们的研究表明,无论阻塞类型如何,黄斑区 IRH 的存在都会对 BCVA 结果产生负面影响。仅在非缺血性 CRVO 病例中观察到视力演变的统计学显著差异,与 EZ 中断的存在相关。外视网膜层 HF 已被证明是视力预后不良的预测因素。视网膜静脉阻塞后,与 BCVA 相关的最重要的非影像学预测因素是年龄和基线 BCVA。CMT 的动态变化仍然与视力波动有微弱的联系。黄斑区 IRH、外视网膜层 HF 和黄斑区 EZ 中断的存在对视力预后有负面影响。CRVO = 中心性视网膜静脉阻塞,BRVO = 分支性视网膜静脉阻塞,CMT = 中央视网膜厚度,IRH = 黄斑区视网膜内出血,HF = 高反射焦点,EZ = 椭圆体带中断,DRIL = 内视网膜层组织紊乱,PVD = 玻璃体后脱离,BCVA = 最佳矫正视力,OCT = 光学相干断层扫描,BCVA Ti = 首次最佳矫正视力,BCVA Tf = 一年后最佳矫正视力,IVI-NR = 玻璃体腔内注射次数,SD = 标准差,M = 男性,F = 女性,CMT Ti = 首次中央视网膜厚度,CMT T1 = 第一次注射后的中央视网膜厚度,CMT T3 = 第三次注射后的中央视网膜厚度,CMT Tf = 一年后的中央视网膜厚度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b219/10591427/f5081d00ddfa/RomJOphthalmol-67-312-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b219/10591427/ea442a0348cc/RomJOphthalmol-67-312-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b219/10591427/f564d5c4acd5/RomJOphthalmol-67-312-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b219/10591427/4b22085809fc/RomJOphthalmol-67-312-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b219/10591427/f5081d00ddfa/RomJOphthalmol-67-312-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b219/10591427/ea442a0348cc/RomJOphthalmol-67-312-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b219/10591427/f564d5c4acd5/RomJOphthalmol-67-312-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b219/10591427/4b22085809fc/RomJOphthalmol-67-312-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b219/10591427/f5081d00ddfa/RomJOphthalmol-67-312-g004.jpg

相似文献

1
Macular dynamics and visual acuity prognosis in retinal vein occlusions - ways to connect.视网膜静脉阻塞的黄斑动力学和视力预后——连接的途径。
Rom J Ophthalmol. 2023 Jul-Sep;67(3):312-324. doi: 10.22336/rjo.2023.51.
2
OPTICAL COHERENCE TOMOGRAPHY PREDICTORS OF SHORT-TERM VISUAL ACUITY IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL CONBERCEPT.玻璃体内注射康柏西普治疗视网膜静脉阻塞继发黄斑水肿患者短期视力的光学相干断层扫描预测指标
Retina. 2020 Apr;40(4):773-785. doi: 10.1097/IAE.0000000000002444.
3
Spectral-Domain OCT Predictors of Visual Outcomes after Ranibizumab Treatment for Macular Edema Resulting from Retinal Vein Occlusion.雷珠单抗治疗视网膜静脉阻塞所致黄斑水肿后视力预后的频域光学相干断层扫描预测指标
Ophthalmol Retina. 2020 Jan;4(1):67-76. doi: 10.1016/j.oret.2019.08.009. Epub 2019 Aug 28.
4
Optical Coherence Tomography Biomarkers Predicting Visual Acuity Change after Intravitreal Bevacizumab Injections for Macular Edema Secondary to Branch Retinal Vein Occlusion.光学相干断层扫描生物标志物预测分支视网膜静脉阻塞性黄斑水肿患者玻璃体内注射贝伐单抗后视力变化
Ophthalmologica. 2022;245(1):19-24. doi: 10.1159/000519373. Epub 2021 Sep 10.
5
Correlation between optical coherence tomographic hyperreflective foci and visual outcomes after intravitreal bevacizumab for macular edema in branch retinal vein occlusion.视网膜分支静脉阻塞性黄斑水肿患者玻璃体内注射贝伐单抗后光学相干断层扫描高反射灶与视觉预后的相关性
Graefes Arch Clin Exp Ophthalmol. 2014 Sep;252(9):1413-21. doi: 10.1007/s00417-014-2595-5. Epub 2014 Mar 1.
6
Collateral Vessel Development in Central and Branch Retinal Vein Occlusions Are Associated With Worse Visual and Anatomic Outcomes.中心性和分支性视网膜静脉阻塞的侧支血管发育与更差的视力和解剖学结局相关。
Invest Ophthalmol Vis Sci. 2021 Nov 1;62(14):1. doi: 10.1167/iovs.62.14.1.
7
Bevacizumab treatment for acute branch retinal vein occlusion accompanied by subretinal hemorrhage.贝伐单抗治疗伴视网膜下出血的急性视网膜分支静脉阻塞
Curr Eye Res. 2015 Jul;40(7):752-6. doi: 10.3109/02713683.2014.952827. Epub 2014 Oct 20.
8
Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.玻璃体内注射贝伐单抗后再行地塞米松植入与地塞米松植入单药治疗视网膜静脉阻塞伴黄斑水肿的比较。
Ophthalmologica. 2012;228(2):110-6. doi: 10.1159/000338732. Epub 2012 Jun 23.
9
Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept.康柏西普治疗视网膜中央静脉阻塞继发黄斑水肿患者的视力恢复的预测因素。
BMC Ophthalmol. 2021 Nov 22;21(1):402. doi: 10.1186/s12886-021-02174-0.
10
Bevacizumab treatment of macular edema in CRVO and BRVO: long-term follow-up. (BERVOLT study: Bevacizumab for RVO long-term follow-up).贝伐单抗治疗视网膜中央静脉阻塞(CRVO)和视网膜分支静脉阻塞(BRVO)所致黄斑水肿:长期随访。(BERVOLT研究:贝伐单抗治疗视网膜静脉阻塞的长期随访)
Graefes Arch Clin Exp Ophthalmol. 2016 May;254(5):835-44. doi: 10.1007/s00417-015-3130-z. Epub 2015 Aug 14.

引用本文的文献

1
Baseline macular structural and vascular changes as predictive markers of visual improvement in central retinal vein occlusion.基线黄斑结构和血管变化作为中心视网膜静脉阻塞视力改善的预测指标。
North Clin Istanb. 2025 Apr 24;12(2):222-230. doi: 10.14744/nci.2025.26932. eCollection 2025.
2
The Diagnosis and Treatment of Branch Retinal Vein Occlusions: An Update.视网膜分支静脉阻塞的诊断与治疗:最新进展
Biomedicines. 2025 Jan 5;13(1):105. doi: 10.3390/biomedicines13010105.

本文引用的文献

1
Foveal Intraretinal Fluid Localization Affects the Visual Prognosis of Branch Retinal Vein Occlusion.黄斑区视网膜内液的定位影响视网膜分支静脉阻塞的视觉预后。
J Clin Med. 2022 Jun 20;11(12):3540. doi: 10.3390/jcm11123540.
2
Potential Prognostic Indicators for Patients With Retinal Vein Occlusion.视网膜静脉阻塞患者的潜在预后指标
Front Med (Lausanne). 2022 May 25;9:839082. doi: 10.3389/fmed.2022.839082. eCollection 2022.
3
Significance of Hyperreflective Foci as an Optical Coherence Tomography Biomarker in Retinal Diseases: Characterization and Clinical Implications.
高反射灶作为视网膜疾病光学相干断层扫描生物标志物的意义:特征与临床意义
J Ophthalmol. 2021 Dec 17;2021:6096017. doi: 10.1155/2021/6096017. eCollection 2021.
4
Collateral Vessel Development in Central and Branch Retinal Vein Occlusions Are Associated With Worse Visual and Anatomic Outcomes.中心性和分支性视网膜静脉阻塞的侧支血管发育与更差的视力和解剖学结局相关。
Invest Ophthalmol Vis Sci. 2021 Nov 1;62(14):1. doi: 10.1167/iovs.62.14.1.
5
Commentary: Hyperreflective foci on optical coherence tomography and their clinical implications in diabetic macular edema.评论:光学相干断层扫描中的高反射灶及其在糖尿病性黄斑水肿中的临床意义
Indian J Ophthalmol. 2021 Nov;69(11):3206-3207. doi: 10.4103/ijo.IJO_2530_21.
6
Ellipsoid Zone Defects in Retinal Vein Occlusion Correlates With Visual Acuity Prognosis: SCORE2 Report 14.视网膜静脉阻塞的椭圆体带缺损与视力预后相关:SCORE2 报告 14 期。
Transl Vis Sci Technol. 2021 Mar 1;10(3):31. doi: 10.1167/tvst.10.3.31.
7
Age, Gender, and Laterality of Retinal Vascular Occlusion: A Retrospective Study from the IRIS® Registry.年龄、性别和视网膜血管闭塞的侧别:来自 IRIS® 登记处的回顾性研究。
Ophthalmol Retina. 2022 Feb;6(2):161-171. doi: 10.1016/j.oret.2021.05.004. Epub 2021 May 12.
8
SCORE2 Report 13: Intraretinal Hemorrhage Changes in Eyes With Central or Hemiretinal Vein Occlusion Managed With Aflibercept, Bevacizumab or Observation. Secondary Analysis of the SCORE and SCORE2 Clinical Trials.SCORE2 报告 13:接受阿柏西普、贝伐珠单抗或观察治疗的中心或半侧视网膜静脉阻塞眼的视网膜内出血变化。SCORE 和 SCORE2 临床试验的二次分析。
Am J Ophthalmol. 2021 Feb;222:185-193. doi: 10.1016/j.ajo.2020.08.030. Epub 2020 Aug 20.
9
Association between Macular Thickness Profiles and Visual Function in Healthy Eyes: The Singapore Epidemiology of Eye Diseases (SEED) Study.健康眼中黄斑厚度曲线与视觉功能的相关性:新加坡眼病流行病学研究(SEED)。
Sci Rep. 2020 Apr 9;10(1):6142. doi: 10.1038/s41598-020-63063-y.
10
Impact and Implication of Fovea-Involving Intraretinal Hemorrhage after Acute Branch Retinal Vein Occlusion.急性视网膜分支静脉阻塞后累及黄斑的视网膜内出血的影响及意义
Ophthalmol Retina. 2019 Sep;3(9):760-766. doi: 10.1016/j.oret.2019.04.005. Epub 2019 Apr 10.